Pharma
As May 2024 begins, the field of Artificial Intelligence enters a transformative phase, highlighted in the latest edition of AIM Research Monthly. Leading this change is the inaugural CDO Vision San Francisco event, the CDO Vision Series by AIM Research. This key event brought together leading minds in the industry, creating a space for collaboration, networking, and the sharing of knowledge. The event focused on the extensive topic of Strategic Decision-Making for Generative AI, encompassing Business Alignment, Talent, and Governance. Set against this vibrant gathering, the May issue of the journal stands as a testament to the revolutionary impact of Generative AI, providing readers with an exclusive look at the latest research, trends, and case studies presented.
CDO Vision San Francisco 2024
At the CDO Vision San Francisco event, discussions focused on responsible AI use in insurance, emphasizing the need for centralized governance, data-driven decision-making, and ethical AI applications. Key initiatives proposed included setting up an AI center of excellence, forming cross-functional teams, enhancing data input for model improvement, and establishing robust infrastructure and monitoring for AI projects. Challenges such as misinformation, limited model access, and the necessity for strong software architecture and continuous infrastructure investment were highlighted, alongside calls for greater transparency and accountability in AI development.
Retiring Legacy and Modernizing Analytics Systems Among Enterprises
The report indicates widespread agreement among businesses on the advantages of transitioning from traditional to contemporary BI systems, focusing on better decision-making and increased operational efficiency. An impressive 82.8% of organizations acknowledge the critical necessity to switch, driven by the superior functionality of modern systems that facilitate real-time analysis and more flexible reporting.
